Guardant Health (GH) PT Lowered to $55 at Barclays
Get Alerts GH Hot Sheet
Price: $163.18 --0%
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 5
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 5
Join SI Premium – FREE
Barclays analyst Luke Sergott lowered the price target on Guardant Health (NASDAQ: GH) to $55.00 (from $60.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Guardant Health to appeal Delaware patent ruling by TwinStrand
- Accent Group Ltd. (AX1:AU) PT Raised to AUD0.77 at Citi
- NIBE Industrier AB (NIBEB:SW) (NDRBF) PT Raised to SEK46 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share